Biomarkers of focal and diffuse traumatic brain injury

Critical Care

Volumn 15, Issue 4, 2011, Pages

  Vos, Pieter E ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; GLIAL FIBRILLARY ACIDIC PROTEIN; UBIQUITIN; UBIQUITIN CARBOXY TERMINAL HYDROLASE L1; UNCLASSIFIED DRUG; UBIQUITIN THIOLESTERASE;

AGE DISTRIBUTION; ASTROCYTE; BRAIN DISEASE; BRAIN HEMATOMA; BRAIN HYPOXIA; BRAIN SWELLING; COMPUTER ASSISTED TOMOGRAPHY; DEMOGRAPHY; FATALITY; GLASGOW COMA SCALE; HUMAN; HYPOTENSION; IMAGE ANALYSIS; INJURY SEVERITY; NERVE INJURY; NOTE; PRIORITY JOURNAL; PROGNOSIS; PUPIL REFLEX; SUBARACHNOID HEMORRHAGE; SURVIVOR; TRAUMATIC BRAIN INJURY; BLOOD; BRAIN INJURY; FEMALE; MALE; RADIOGRAPHY;

BRAIN INJURIES; FEMALE; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; MALE; TOMOGRAPHY, X-RAY COMPUTED; UBIQUITIN THIOLESTERASE;

EID: 84860855532     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc10290     Document Type: Note

References (9)

1. Mondello S, Papa L, Buki A, Bullock R, Czeiter E, Tortella F, Wang KK, Hayes RL. Neuronal and glial markers are differently associated with computed tomography findings and outcome in patients with severe traumatic brain injury: a case control study. Crit Care 2011, 15:R156. 10.1186/cc10286, 3219030, 21702960.
2. Steyerberg EW, Mushkudiani N, Perel P, Butcher I, Lu J, McHugh GS, Murray GD, Marmarou A, Roberts I, Habbema JD, Maas AI. Predicting outcome after traumatic brain injury: development and international validation of prognostic scores based on admission characteristics. PLoS Med 2008, 5:e165. 10.1371/journal.pmed.0050165, 2494563, 18684008.
3. Perel P, Arango M, Clayton T, Edwards P, Komolafe E, Poccock S, Roberts I, Shakur H, Steyerberg E, Yutthakasemsunt S. MRC CRASH Trial Collaborators Predicting outcome after traumatic brain injury: practical prognostic models based on large cohort of international patients. BMJ 2008, 336:425-429. 2249681, 18270239, MRC CRASH Trial Collaborators.
4. Lingsma HF, Roozenbeek B, Steyerberg EW, Murray GD, Maas AI. Early prognosis in traumatic brain injury: from prophecies to predictions. Lancet Neurol 2010, 9:543-554. 10.1016/S1474-4422(10)70065-X, 20398861.
5. Saatman KE, Duhaime AC, Bullock R, Maas AI, Valadka A, Manley GT. Classification of traumatic brain injury for targeted therapies. J Neurotrauma 2008, 25:719-738. 10.1089/neu.2008.0586, 2721779,2721779, 18627252.
6. Tongaonkar P, Chen L, Lambertson D, Ko B, Madura K. Evidence for an interaction between ubiquitin-conjugating enzymes and the 26S proteasome. Mol Cell Biol 2000, 20:4691-4698. 10.1128/MCB.20.13.4691-4698.2000, 85887, 10848595.
7. Vos PE, Jacobs B, Andriessen TM, Lamers KJ, Borm GF, Beems T, Edwards M, Rosmalen CF, Vissers JL. GFAP and S100B are biomarkers of traumatic brain injury: an observational cohort study. Neurology 2010, 75:1786-1793. 10.1212/WNL.0b013e3181fd62d2, 21079180.
8. Pelinka LE, Kroepfl A, Schmidhammer R, Krenn M, Buchinger W, Redl H, Raabe A. Glial fibrillary acidic protein in serum after traumatic brain injury and multiple trauma. J Trauma 2004, 57:1006-1012. 10.1097/01.TA.0000108998.48026.C3, 15580024.
9. Skandsen T, Kvistad KA, Solheim O, Strand IH, Folvik M, Vik A. Prevalence and impact of diffuse axonal injury in patients with moderate and severe head injury: a cohort study of early magnetic resonance imaging findings and 1-year outcome. J Neurosurg 2010, 113:556-563. 10.3171/2009.9.JNS09626, 19852541.